Atlas Trials

Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial

Clinical trial NCT02349009 · COMPLETED

Trial details

NCT number
NCT02349009
Sponsor
Prism Pharma Co., Ltd.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Systemic Scleroderma
Start date
2015-06-01
Primary completion
2016-07-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.